Latest Insider Transactions at H Cyte, Inc. (HCYTD)
This section provides a real-time view of insider transactions for H Cyte, Inc. (HCYTD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of H-CYTE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of H-CYTE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 16
2024
|
Todd R Wagner > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
303,107
+46.79%
|
-
|
|
Jan 16
2024
|
J Rex Farrior Iii > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
13,168
+30.95%
|
-
|
|
Mar 21
2022
|
Frederick J Lynch > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
8,321,785
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 23
2022
|
Todd R Wagner > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
41,608,884
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 23
2022
|
J Rex Farrior Iii > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
693,477
+4.1%
|
$0
$0.01 P/Share
|
|
Jun 29
2021
|
Michael Yurkowsky Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
69,500
-0.53%
|
$0
$0.18 P/Share
|
|
Jul 23
2020
|
J Rex Farrior Iii > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
15,518,111
+50.0%
|
$0
$0.41 P/Share
|